Kenneth M. Ferguson serves as Executive at Cyclacel Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Kenneth M. Ferguson has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 30, 2023 involved receiving (via award) 21,219 shares valued at $0.
Kenneth M. Ferguson currently holds 44,952 shares of Cyclacel Pharmaceuticals, Inc. (CYCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth M. Ferguson has been a net neutral trader of CYCC stock. They have purchased $0 and sold $0 worth of shares.
Kenneth M. Ferguson's most recent insider trade was on Jun 30, 2023, when they sold 21,219 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 14, 2022 | CYCC | $0 | Award | 23,733 | $N/A | Discretionary |